FMR LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,000
-100.0%
200
-100.0%
0.00%
-100.0%
Q4 2020$6,206,000
-91.8%
1,261,285
-60.1%
0.00%
-87.5%
Q3 2020$76,029,000
-37.9%
3,159,941
+0.1%
0.01%
-38.5%
Q2 2020$122,475,000
+16.4%
3,158,207
+4.4%
0.01%
-13.3%
Q1 2020$105,199,000
+7.0%
3,026,452
+41.3%
0.02%
+36.4%
Q4 2019$98,316,0002,142,4280.01%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders